MSMB has been studied by a large number of groups as a putative prostate cancer biomarker because levels in tissue and serum is reduced or lost with cancer development [2], [3], [4], [12], [20], [21], [22], [23] (Figure 1B). Here, MSMB is linked to prostate carcinoma.